ResultsIQ

ResultsIQ › Latest results › Nucleus Software Exports Limited

Nucleus Software Exports Limited Q1 FY26 earnings call summary

NSE: NUCLEUS · BSE: 531209

Earnings call of 1 Aug 2025, summarised by AI from the filing.

Q1 FY26 consolidated revenue ₹217.72 cr (Q4 FY25: ₹228.96 cr, Q1 FY25: ₹195.39 cr).

Key takeaways

  1. Revenue Q1 FY26 consolidated revenue ₹217.72 cr (Q4 FY25: ₹228.96 cr, Q1 FY25: ₹195.39 cr).
  2. Margin recovery Management aims to increase top line to get back to last year's margins, relying on new sales.
  3. Go-lives Went live with FinnOne Neo collections transformation with over 20,000 users; HNB and Federal Bank live on FinnAxia.
  4. CFO exit Former CFO resigned without notice after the prior earnings call; management said they had no choice.

Original filing on BSE

Nucleus Software Exports Limited Q1 FY27 results

As filed: Revenue ₹210 cr (−3% year on year), EBITDA ₹8.0 cr (−76% year on year), PAT ₹23.9 cr (−58% year on year), EBITDA margin 3.8% (−1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹225 cr (−2% year on year), EBITDA ₹35.0 cr (−53% year on year), PAT ₹34.6 cr (−47% year on year), EBITDA margin 15.6% (−1,000 bps). Score 28 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 1000 bps year on year. Other income 36% of PBT. Revenue fell 95% from last quarter. Share price after the results: −1.2% in 29 days (Nifty 500: +2.5%).
  • Q3 FY26: Revenue ₹4,188 cr (+300% year on year), EBITDA ₹730 cr (+300% year on year), PAT ₹297 cr (+300% year on year), EBITDA margin 17.4% (+142 bps). Score 100 of 100, Above trend. Revenue, EBITDA and profit before exceptional items growth were well above the company's own trend. EBITDA margin rose 142 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −7.7% in 29 days (Nifty 500: +1.7%).
  • Q2 FY26: Revenue ₹214 cr (+6% year on year), EBITDA ₹23.0 cr (−28% year on year), PAT ₹26.0 cr (−21% year on year), EBITDA margin 10.8% (−509 bps). Score 32 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 509 bps year on year. Other income 46% of PBT. Profit fell 26% from last quarter. Share price after the results: −11.7% in 30 days (Nifty 500: 0.0%).
  • Q1 FY26: Revenue ₹218 cr (+12% year on year), EBITDA ₹33.0 cr (+14% year on year), PAT ₹35.0 cr (+17% year on year), EBITDA margin 15.1% (+27 bps). Score 59 of 100, In line with trend. Revenue, EBITDA and profit growth were above the company's own trend. EBITDA margin rose 27 bps year on year. Other income 38% of PBT. Revenue fell 5% from last quarter. Share price after the results: 0.0% in 29 days (Nifty 500: −2.5%).
  • Q4 FY25: Revenue ₹229 cr (+9% year on year), EBITDA ₹74.0 cr (+28% year on year), PAT ₹65.0 cr (+25% year on year), EBITDA margin 32.3% (+470 bps). Score 77 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 470 bps year on year. Share price after the results: +19.6% in 28 days (Nifty 500: +0.5%).
  • Q3 FY25: Revenue ₹206 cr (+1% year on year), EBITDA ₹33.0 cr (−31% year on year), PAT ₹35.0 cr (−15% year on year), EBITDA margin 16.0% (−751 bps). Score 30 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin fell 751 bps year on year. Other income 36% of PBT.
  • Q2 FY25: Revenue ₹202 cr (−1% year on year), EBITDA ₹32.0 cr (−38% year on year), PAT ₹33.0 cr (−27% year on year), EBITDA margin 15.8% (−952 bps). Score 5 of 100, Below trend. EBITDA margin fell 952 bps year on year. Other income 40% of PBT. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Nucleus Software Exports Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.